Israel, R., Mishell, D. R., Jr., Stone, S. C., Thorneycroft, I. H., & Moyer, D. L. (1972). Single luteal phase serum progesterone assay as an indicator of ovulation. American Journal of Obstetrics and Gynecology, 112(8), 1043-1046. https://doi.org/10.1016/0002-9378(72)90178-0
Israel R, Mishell DR Jr, Stone SC, Thorneycroft IH, Moyer DL. Single luteal phase serum progesterone assay as an indicator of ovulation. Am J Obstet Gynecol. 1972;112(8):1043-1046. doi:10.1016/0002-9378(72)90178-0
Israel, Robert, et al. "Single luteal phase serum progesterone assay as an indicator of ovulation." American Journal of Obstetrics and Gynecology, vol. 112, no. 8, 1972, pp. 1043-1046.
A single midluteal progesterone blood test suggests ovulation
One blood test in the middle of the luteal phase suggested that ovulation had happened in that cycle. A 1972 study found this in 51 infertile women with regular periods and 35 women on clomiphene. Among women biopsied, samples above the authors' cutoff came with a secretory uterine lining.
Key Findings
Daily blood samples from 13 regularly cycling women showed progesterone rising 1 or 2 days after the LH peak. Each of the 13 cycles had a biphasic basal body temperature curve.
Among 72 single follicular-phase samples from 44 women, none reached the authors' cutoff, and most were undetectable.
Among 51 infertile women with regular menses, luteal samples taken 11 to 4 days before menstruation all exceeded the cutoff. All 42 biopsies showed secretory endometrium, except one taken 14 days before.
In 35 women on clomiphene citrate, 30 of 71 courses brought no withdrawal bleeding. Those 30 biopsies all showed proliferative endometrium, and every progesterone result fell below the cutoff.
For 41 courses followed by bleeding, samples taken more than 4 and fewer than 11 days beforehand all exceeded the cutoff. All 23 biopsies showed secretory endometrium.
Interpretation
This 1972 study followed 51 infertile women with regular periods and 35 women taking clomiphene. Each woman gave one blood sample partway through the luteal phase. Researchers compared the progesterone level to a biopsy of the uterine lining and to the timing of bleeding. High progesterone matched a secretory lining every time. Low progesterone matched a proliferative lining in every clomiphene cycle that had no bleeding. The authors call this a presumptive sign of ovulation. The findings support larger studies of this single blood test as an ovulation marker.
RRM Context
Restorative reproductive medicine treats ovulation as the central, confirmable event of the cycle. NaProTechnology times a midluteal progesterone test to a woman's own cycle chart to confirm that ovulation occurred. Cycle charting is what makes that timing possible.
Our editorial summary of this paper, not the article's abstract.
Abstract
A study was undertaken to determine whether solitary progesterone as says performed on serum samples obtained in the midluteal phase would provide the clinician with a convenient indicator that ovulation had occurred in that cycle. After a normal luteal-phase range was establish ed, single luteal-phase serum progesterone sampling was performed in 51 infertile women with regular menses and 35 oligomenorrheic women undergoing clomiphene citrate therapy. In the follicular phase of the cycle, progesterone levels were consistently less than 2 ng/ml. Between 11 and 4 days prior to the onset of menses in presumptively ovulatory cycles, serum progesterone levels were always 3 ng/ml or greater. Progesterone values in this range were always accompanied by a secretory endometrium and can be considered presumptive evidence of ovulation. This rapid, easily performed technique enables 1 technician to assay 30 or more samples for progesterone in a single working day and the results are available within 24 hours. This assay technique is easier to perform and more reproducible than a urinary pregnanediol assay, and it is expected that clinical laboratories will soon perform serum progesterone assays as a routine procedure.